UNICA IRIS Institutional Research Information System

BARCELLONA, DORIS
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 124.475
NA - Nord America 9.545
AS - Asia 3.986
SA - Sud America 774
Continente sconosciuto - Info sul continente non disponibili 543
AF - Africa 186
OC - Oceania 64
Totale 139.573
Salva come PNG Salva come JPEG
Nazione #
IT - Italia 122.264
US - Stati Uniti d'America 9.254
SG - Singapore 1.450
CN - Cina 1.102
BR - Brasile 584
SE - Svezia 472
VN - Vietnam 419
GB - Regno Unito 342
DE - Germania 308
UA - Ucraina 260
FI - Finlandia 194
HK - Hong Kong 191
FR - Francia 169
CA - Canada 157
BD - Bangladesh 145
IN - India 128
NL - Olanda 92
KR - Corea 65
AR - Argentina 61
JP - Giappone 60
MX - Messico 60
TR - Turchia 54
AU - Australia 52
IQ - Iraq 52
ZA - Sudafrica 50
ES - Italia 46
PL - Polonia 44
AT - Austria 43
IE - Irlanda 43
RU - Federazione Russa 41
PK - Pakistan 40
IR - Iran 36
ID - Indonesia 35
CO - Colombia 33
EG - Egitto 33
MA - Marocco 32
EC - Ecuador 26
DK - Danimarca 23
IL - Israele 22
MY - Malesia 21
UZ - Uzbekistan 21
BE - Belgio 20
PH - Filippine 19
SA - Arabia Saudita 19
CH - Svizzera 18
JM - Giamaica 18
TW - Taiwan 16
KE - Kenya 15
PY - Paraguay 15
CL - Cile 14
PE - Perù 14
JO - Giordania 13
TN - Tunisia 13
ET - Etiopia 12
LT - Lituania 12
VE - Venezuela 12
BG - Bulgaria 11
CR - Costa Rica 11
CZ - Repubblica Ceca 11
NP - Nepal 11
NZ - Nuova Zelanda 11
AE - Emirati Arabi Uniti 9
HU - Ungheria 8
SD - Sudan 8
DZ - Algeria 7
PR - Porto Rico 7
RO - Romania 7
TH - Thailandia 7
PT - Portogallo 6
UY - Uruguay 6
BH - Bahrain 5
CY - Cipro 5
HN - Honduras 5
KZ - Kazakistan 5
NO - Norvegia 5
AZ - Azerbaigian 4
BA - Bosnia-Erzegovina 4
BY - Bielorussia 4
GE - Georgia 4
GT - Guatemala 4
GY - Guiana 4
KG - Kirghizistan 4
LB - Libano 4
LV - Lettonia 4
MU - Mauritius 4
NI - Nicaragua 4
OM - Oman 4
PA - Panama 4
SC - Seychelles 4
SV - El Salvador 4
BO - Bolivia 3
DO - Repubblica Dominicana 3
EU - Europa 3
KW - Kuwait 3
LK - Sri Lanka 3
LU - Lussemburgo 3
MT - Malta 3
RS - Serbia 3
SK - Slovacchia (Repubblica Slovacca) 3
SY - Repubblica araba siriana 3
Totale 138.989
Salva come PNG Salva come JPEG
Città #
Cagliari 116.069
Uta 5.357
Ashburn 1.105
Fairfield 765
Singapore 679
Dallas 540
Woodbridge 526
San Jose 516
Houston 405
Boardman 315
Seattle 311
Council Bluffs 305
Nyköping 291
Chandler 290
Wilmington 288
Cambridge 262
Ann Arbor 246
Beijing 236
Los Angeles 194
Hong Kong 166
Santa Clara 162
New York 154
Helsinki 137
Jacksonville 134
Ho Chi Minh City 121
The Dalles 120
Shanghai 103
Lauterbourg 95
Dearborn 93
Boston 90
Rome 88
Hanoi 79
Milan 72
Buffalo 68
Chicago 64
São Paulo 62
Dong Ket 58
San Diego 58
Toronto 55
Nanjing 52
Munich 51
Hefei 48
Seoul 47
Redwood City 42
Nuremberg 41
Phoenix 41
Frankfurt am Main 39
Redondo Beach 38
Tokyo 38
Guangzhou 37
Columbus 36
Denver 36
Dublin 31
Brooklyn 30
London 30
Warsaw 29
Vienna 28
San Francisco 27
Atlanta 26
Johannesburg 25
Orem 25
Shenyang 25
Stockholm 23
Brandenburg 22
Montreal 22
Amsterdam 21
Mexico City 21
Chennai 20
Sydney 20
Tashkent 20
Tianjin 20
Naples 19
Ankara 18
Baghdad 18
Hebei 18
Rio de Janeiro 18
Selargius 18
Bogotá 17
Brussels 17
Haiphong 17
Manchester 17
Turku 17
Changsha 16
College Station 16
Lahore 16
Nanchang 16
North Bergen 16
Redmond 15
Central 14
Jiaxing 14
Nairobi 14
Salt Lake City 14
Mountain View 13
Mumbai 13
Norwalk 13
Amman 12
Istanbul 12
Orange 12
Sassari 12
Baoding 11
Totale 132.133
Salva come PNG Salva come JPEG
Nome #
Abnormal lipid accumulation and cluster formation of naive peripheral blood mononuclear cells: a useful tool for early detection of central nervous system damage in elderly 2.898
Heterogeneity of Antiphospholipid Syndrome (APS) as Characterized by Brain Perfusion Techniques. Towards New Ways of Syndrome Characterization 2.828
The venous thromboembolic risk and the clot wave analysis: a useful relationship? 2.789
Prophylaxis of peripartum haemorrhage using recombinant factor VIIa (rfVIIa) in pregnant women with congenital factor VII deficiency: A case report and literature review 2.768
Myocardial infarction and Antiphospholipid Syndrome: A first study on finger PPG waveforms effects 2.591
Dabigatran overdose: a case report of acute hepatitis. Extracorporeal treatment. 2.588
Olanzapine-associated portal and superior mesenteric vein thrombosis 2.529
Are prothrombin time and clot waveform analysis useful in detecting a bleeding risk in liver cirrhosis? 2.453
Telemedicine can improve the quality of oral anticoagulation using portable devices and self-testing at home 2.326
Clot wave analysis and thromboembolic score in liver cirrhosis: two opposing phenomena 2.309
Empathy and the Educational Approach to Patients With Atrial Fibrillation Treated With Direct Oral Anticoagulants 2.197
Underuse of anticoagulant therapy in hospitalized older patients: comment on the article of Wojszel et al 2.180
Management of Patients Taking Oral Anticoagulants Who Need Urgent Surgery for Hip Fracture 2.169
Multiple specialized stem cell niches characterize hematopoiesis in the human fetal liver 2.094
Pulmonary Thrombosis: A Clinical Pathological Entity Distinct from Pulmonary Embolism? 2.088
Clot Waveform Analysis: From Hypercoagulability to Hypocoagulability - A Review 2.044
A Sardinian Family with Factor XI Deficiency 2.005
Ultrastructural findings of lung injury due to Vaccine-induced Immune Thrombotic Thrombocytopenia (VITT) following COVID-19 vaccination: a scanning electron microscopic study 2.001
Vaccine-induced severe thrombotic thrombocytopenia following COVID-19 vaccination: A report of an autoptic case and review of the literature 1.932
A “Catastrophic” Heparin-Induced Thrombocytopenia 1.900
The hemostatic system. 1st Part 1.831
Points of Care Testing International Normalized Ratio: Are They Useful for Monitoring Vitamin K Antagonists in a Thrombosis Center? 1.818
Molecular pathways triggered by COVID-19 in different organs: ACE2 receptor-expressing cells under attack? A review 1.777
Point-of-care testing INR: an overview 1.690
Has time come for the use of direct oral anticoagulants in the extended prophylaxis of venous thromboembolism in acutely ill medical patients? No 1.672
Pulmonary thrombosis in 2019-nCoV pneumonia? 1.664
Risk of reoperation in bioprosthetic valve patients with indication for longterm anticoagulation. Results from the observational retrospective multicentre PLECTRUM study 1.655
Rivaroxaban vs warfarin in high-risk patients with antiphospholipid syndrome 1.638
Patients' adherence to oral anticoagulants therapy: Comparison between vitamin K antagonists and direct oral anticoagulants 1.616
Mechanical prosthetic heart valves: Quality of anticoagulation and thromboembolic risk. The observational multicenter PLECTRUM study 1.591
Direct oral anticoagulants: what can we learn? 1.577
Comparison of prothrombin time INR and clot waveform analysis performed with 129-mmol/L and 105-mmol/L citrate tubes 1.567
Fatal Cytopenia Induced by Low-Dose Methotrexate in Elderly With Rheumatoid Arthritis. Identification of Risk Factors 1.519
The criteria of the Italian Federation of Thrombosis Centres on DOACs: a ‘‘real world’’ application in nonvalvular atrial fibrillation patients already on Vitamin K Antagonist 1.495
Allele 4G of gene PAI-I associated with prothrombin mutation G20210A increases the risk for venous thrombosis 1.485
Thrombosis centres and AVKs monitoring in COVID-19 pandemic 1.458
Ultrasound-guided fine-needle aspiration biopsy of thyroid nodules in patients on oral anticoagulants 1.396
Fondaparinux: Should It Be Studied in Patients with COVID-19 Disease? 1.374
Direct inhibitors of thrombin and factor Xa: the importance of laboratory skills 1.360
Hyperhomocysteinemia: could the post-methionine oral loading test sometimes be avoided? 1.341
A guide to oral anticoagulation 1.341
Findings from a multicentre, observational study on reproductive outcomes in women with unexplained recurrent pregnancy loss: the OTTILIA registry 1.332
The Repeatable Battery for the Assessment of Neuropsychological Status as a screening strategy for HIV-Associated Neurocognitive Disorders 1.322
Portable coagulometer for vitamin K-antagonist monitoring: the patients’ point of view 1.315
The Italian START-Register on anticoagulation with focus on atrial fibrillation 1.273
Antiphospholipid syndrome patients: The performance of Coagucheck XS in the monitoring of Vitamin K-Antagonists 1.263
Heparins and 2019-nCoV infection: a narrative review 1.261
A ‘‘two-step’’ educational approach for patients taking oral anticoagulants does not improve therapy control 1.243
Thyroid disorders and hypocoagulability 1.213
The predictive ability of bleeding risk stratification models in very old patients on vitaminK antagonist treatment for venous thromboembolism: results of the prospective collaborative EPICA study 1.188
Clinical course of high-risk patients diagnosed with antiphospholipid syndrome 1.163
High frequency of inadequate test requests for antiphospholipid antibodies in daily clinical practice 1.149
Vitamin K antagonists (coumarins), drugs used in the prevention and treatment of cardioembolism, deep vein thrombosis, and pulmonary embolism 1.137
Liver changes in Wilson’s disease: The full spectrum. A report of 127 biopsies from 43 patients 1.134
Fetal programming of atherosclerosis: may the barker hypothesis explain the susceptibility of a subset of patients to develop stroke or cardiac infarct? 1.115
Anticoagulation resumption after intracranial hemorrhage in patients treated with VKA and DOACs 1.097
Association of Antiplatelet and Anticoagulant Treatment in Patients with Mechanical Prosthetic Heart Valves. Data from the Observational Multicentre PLECTRUM Study 1.089
Rheumatoid arthritis and thrombosis 1.088
A routine silica-based activated partial thromboplastin time (Hemosil aPTT-SP (TM)) mostly excludes the presence of lupus anticoagulant 1.087
Prevalence and significance of anti-prothrombin (aPT) antibodies in patients with Lupus Anticoagulant (LA) 1.079
Fetal programming of COVID-19: May the barker hypothesis explain the susceptibility of a subset of young adults to develop severe disease? 1.032
Infectious agents including COVID-19 and the involvement of blood coagulation and fibrinolysis. A narrative review 1.029
Point-of-care (POCT) prothrombin time monitors: is a periodical control of their performance useful? 1.022
Clot characterization by multidisciplinary approach: biochemical and imaging parameters in a hypocoagulative setting. A pilot study 1.020
Management of DOAC in patients undergoing planned surgery or invasive procedure: FCSA position paper 1.004
Position paper on the safety/efficacy profile of Direct Oral Anticoagulants in patients with Chronic Kidney Disease: Consensus document of Società Italiana di Nefrologia (SIN), Federazione Centri per la diagnosi della trombosi e la Sorveglianza delle terapie Antitrombotiche (FCSA) and Società Italiana per lo Studio dell’Emostasi e della Trombosi (SISET) 949
Thrombotic sinusoiditis and local diffuse intrasinusoidal coagulation in the liver of subjects affected by COVID-19: The evidence from histology and scanning electron microscopy 939
Aortic vulnerability to COVID-19: Is the microvasculature of vasa vasorum a key factor? A case report and a review of the literature 914
The management of acute venous thromboembolism in clinical practice - study rationale and protocol of the European PREFER in VTE Registry 870
Scanning electron microscopy of lung disease due to COVID-19 – a case report and a review of the literature 860
Managing anticoagulation in the COVID-19 era between lockdown and reopening phases 855
Chronic intravascular coagulation in liver cirrhosis predicts a high hemorrhagic risk 853
null 845
Chronic spontaneous urticaria: a low-grade disseminated intravascular coagulation only partially reversed by Omalizumab 843
Trial of Rivaroxaban in AntiPhospholipid Syndrome (TRAPS): Two-year outcomes after the study closure 835
null 824
Clinical history and gastrointestinal bleeding in patients taking oral anticoagulants 802
Sex-based difference in anticoagulated patients with mechanical prosthetic heart valves and long-term mortality risk 799
null 789
null 772
Comparison of anticoagulation quality between acenocoumarol and warfarin in patients with mechanical prosthetic heart valves: Insights from the nationwide PLECTRUM study 759
Position paper on the safety/efficacy profile of direct oral anticoagulants in patients with chronic kidney disease. Consensus document from the SIN, FCSA and SISET 754
Bleeding risk in very old patients on vitamin K antagonist treatment: results of a prospective collaborative study on elderly patients followed by Italian Centres for Anticoagulation 703
null 679
null 644
null 633
null 617
null 616
null 579
null 573
null 547
Over-anticoagulation by vitamin K antagonists and gender differences 504
null 491
Hormones and thrombosis: the dark side of the moon 482
Contraceptives and Thrombosis: An Intertwined Revolutionary Road 469
Performance and Interpretation of Clot Waveform Analysis 445
Why Does Rivaroxaban Not Work in Severe Mitral Stenosis? 441
null 440
null 436
Warfarin or acenocoumarol: which is better in the management of oral anticoagulants? 423
Totale 131.193
Salva come PNG Salva come JPEG
Categoria #
all - tutte 192.380
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 192.380
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20227.182 0 0 0 537 721 713 592 531 736 1.001 1.211 1.140
2022/202313.379 1.232 1.857 1.848 1.245 1.120 1.335 652 807 810 790 1.035 648
2023/202413.823 467 803 537 943 1.426 2.090 2.356 985 649 888 1.324 1.355
2024/202530.800 6.688 8.193 5.287 2.871 2.602 1.759 2.007 130 330 426 212 295
2025/20268.219 490 285 1.006 703 625 496 1.325 520 684 1.162 652 271
2026/20272.533 269 524 589 1.151 0 0 0 0 0 0 0 0
Totale 139.573